Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations

Annals of Thoracic Surgery

Volumn 61, Issue 4, 1996, Pages 1188-1193

  Primack, Craig ^a   Walenga, Jeanine M ^a   Koza, Michael J ^a   Shankey, T Vincent ^a   Pifarré, Roque ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BETA3 INTEGRIN; FIBRINOGEN RECEPTOR; HEMOSTATIC AGENT; INTEGRIN; LEUKOCYTE ANTIGEN; PADGEM PROTEIN; SERINE PROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD; CARDIOPULMONARY BYPASS; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; INSTRUMENTATION; INTRAOPERATIVE PERIOD; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; STATISTICS; THROMBOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; APROTININ; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HEMOSTATICS; HUMANS; INTEGRIN BETA3; INTEGRINS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; SERINE PROTEINASE INHIBITORS;

EID: 0030119333     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00016-1     Document Type: Article

References (16)

1. Mohr R, Goor D, Lusky A, Lavee J. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction, a scanning electron microscope study. Circulation 1992; 86(Suppl 2):405-9.
2. Lavee J, Savion N, Simolinsky A, Goor DA, Mohr R. Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study. Ann Thorac Surg 1992;53:477-81.
3. Holloway DS, Summaria L, Sandesara J, et al. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988;59:62-7.
4. Walenga JM, Koza MJ, Hoppensteadt DA, Sullivan HJ, Montoya A, Pifarre R. Fibrinolysis and the antifibrinolytic activity of aprotinin in cardiac surgery. In: Pifarre R, ed. Blood conservation with aprotinin. Philadelphia: Hanley & Belfus, 1995:185-97.
5. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-97.
6. Blauhut B, Gross C, Necek S, Doran JE, Späth P, Lundsgaard-Hansen P. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;101:958-67.
7. Rinder CS, Bonan HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992;79:1201-5.
8. Lu H, DuBuit C, Soria J, et al. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy. Thromb Haemost 1994; 72:438-43.
9. Lu H, Soria C, Commin PL, et al. Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol). Thromb Haemost 1991;66:633-7.
10. Huang H, Ding W, Zhaokang S, Zhang W. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993;106: 11-8.
11. Louie MI, Koza MJ, Walenga JM, Pifarré R. The effect of aprotinin on platelet function in cardiopulmonary bypass patients. Blood 1992;80(Suppl 1):492a.
12. Koza MJ, Shankey TV, Walenga JM, Moncada R, Fareed J, Pifarré R. Flow cytometric evaluation of platelet activation by ionic or nonionic contrast media and modulation by heparin and recombinant hirudin. Invest Radiol 1995;30:90-7.
13. Shattil SJ, Cummingham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987;70:307-15.
14. Kestin AS, Valeri R, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993;82:107-17.
15. 4 cooperative synthesis. Thromb Haemost 1994;72:450-6.
16. Solum NO, Rubach-Dahlberg E, Pedersen TM, Reisberg T, Høgåsen K, Funderud S. Complement-mediated permeabilization of platelets by monoclonal antibodies to CD9: inhibition by leupeptin, and effects on the GPIb-actin-binding protein system. Thromb Res 1994;75:437-52.